8/5/20 8/5/20

WeedMD Signs Exclusive Licensing Agreement with Mary’s Medicinals for Premium Line of Wellness Products

Award-winning products to be manufactured by CX Industries in Canada starting Q4 2020, for sale across all WeedMD’s medical and adult-use channels

7/27/20 7/27/20

WeedMD Announces Resignation of Dr. Hugh Scully from Board of Directors

Dr. Scully was recently reappointed to the Board of Directors, but a personal matter has arisen which has led him to submit his resignation.

7/24/20 7/24/20

WeedMD Appoints Canadian Entrepreneur Bruce Croxon to Board of Directors and Reports Results of AGM

Bruce Croxon is a prominent Canadian entrepreneur and venture capitalist and co-founder of Lavalife.

7/20/20 7/20/20

WeedMD Partners with CannTx Life Sciences to Enhance Genetics Bank of New Cultivars and Preserve its Elite Proprietary Cannabis Strains

University of Guelph-affiliated company to provide WeedMD with innovative tissue cultured-plant services via Steadystem Solutions for cloning accuracy and plant asset preservation

7/15/20 7/15/20

WeedMD Reports First Quarter 2020 Financial Results and Posts Record Revenue of $12.2 Million

WeedMD announced today its financial results for the three months ended March 31, 2020.

7/14/20 7/14/20

WeedMD Cultivars Included in UHN-led Chronic Pain Study

Company’s products on ‘Medical Cannabis by Shoppers’ platform, registered under blockchain-enabled program added to University Health Network’s research trials

7/2/20 7/2/20

WeedMD Announces Amendments to Existing Credit Facility

Amendments to the terms of the Company’s $39 million senior secured credit facility provide WeedMD with greater financial flexibility

6/25/20 6/25/20

WeedMD Reaffirms Record Q1 2020 Preliminary Net Revenues of $12 Million and Confirms Earnings Call on July 15, 2020

Sequential 325% quarter-over-quarter growth signals strong demand and brand recognition

6/22/20 6/22/20

WeedMD Launches Cannabis 2.0 Product Line of Medical Vaporizers

Strain-specific ‘Aurum’ vapes produced in-house at Company’s CX Industries’ facility expands Company’s medical product portfolio

6/18/20 6/18/20

WeedMD Launches Same-Day Medical Cannabis Delivery Service

Pilot project ‘PatientDirect’ kicks off in June with express delivery to Toronto-area patients

6/12/20 6/12/20

WeedMD Completes Planting Cannabis on its 27-Acre Outdoor Field and Provides Operational Update on CX Industries

Kicks-off second-year outdoors with over 18,000 plants slated for fall harvest, confirms 2019 outdoor biomass now in extraction for new cannabis formats at CX Industries

6/10/20 6/10/20

WeedMD Reports Fiscal Year 2019 Financial Results and First Quarter 2020 Preliminary Revenue of $12 Million

WeedMD announced today its financial results for the fiscal year ended December 31, 2019, including a 162% net revenue increase to $20.8 million, compared with $8.0 million for the prior year.

5/28/20 5/28/20

WeedMD to File First Quarter 2020 Financials on or Before July 15

WeedMD announced today that it will file its financial statements for the first quarter ended March 31, 2020 on or before July 15, 2020.

5/19/20 5/19/20

WeedMD Realigns Reporting Dates and Confirms Fiscal Year 2019 Financials to be Filed After Market on June 10, 2020

The Company will host a conference call on Thursday, June 11, 2020, at 10 a.m. ET.

5/6/20 5/6/20

WeedMD to Present in Canaccord Genuity’s 4th Annual Global Cannabis Virtual Conference on May 12th at 8:40 a.m. ET

WeedMD is pleased to announce that Angelo Tsebelis, Chief Executive Officer and Stephen Ng, Chief Commercial Officer, will be presenting in Canaccord Genuity’s 4th Annual Global Cannabis Virtual Conference.

4/23/20 4/23/20

WeedMD to Report its Fiscal Year 2019 Financials on May 27, 2020

Company provides corporate update including COVID-19 impact and confirms earnings conference call will be held on Thursday, May 28, 2020 at 10 a.m. Eastern Time